Compositions for Treatment of Cancer

作者: Carl H. June , Michael D. Kalos , Michael C. Milone , David L. Porter , Bruce L. Levine

DOI:

关键词:

摘要: The present invention provides compositions and methods for treating cancer in a human. includes relates to administering genetically modified T cell express CAR wherein the comprises an antigen binding domain, transmembrane costimulatory signaling region, CD3 zeta domain.

参考文章(126)
Simon Olivares, Pallavi Manuri, Laurence J.N. Cooper, Compositions and methods related to a human cd19-specific chimeric antigen receptor (h-car) ,(2009)
FM Uckun, W Jaszcz, JL Ambrus, AS Fauci, K Gajl-Peczalska, CW Song, MR Wick, DE Myers, K Waddick, JA Ledbetter, Detailed Studies on Expression and Function of CD19 Surface Determinant by Using B43 Monoclonal Antibody and the Clinical Potential of Anti-CD19 Immunotoxins Blood. ,vol. 71, pp. 13- 29 ,(1988) , 10.1182/BLOOD.V71.1.13.13
Hartmut Dohner, Konstanze Fischer, Martin Bentz, Katrin Hansen, Axel Benner, Georges Cabot, Daniela Diehl, Richard Schlenk, Johannes Coy, Stephan Stilgenbauer, Martin Volkmann, Peter R Galle, Annemarie Poustka, Werner Hunstein, Peter Lichter, p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias Blood. ,vol. 85, pp. 1580- 1589 ,(1995) , 10.1182/BLOOD.V85.6.1580.BLOODJOURNAL8561580
Stephen M. G Gottschalk, David M. Spencer, Donald R. Shaffer, Chimeric cd27 receptors for redirecting t cells to cd70-positive malignancies ,(2011)
Claudia Rossig, Cliona Rooney, Malcolm Brenner, Bi-spcific chimeric T cells ,(2002)
Charles L. Sentman, Tong Zhang, NKP30 receptor targeted therapeutics ,(2012)
Gideon Gross, Zelig Eshhar, Endowing cells with antibody specificity using chimeric t cell receptor The FASEB Journal. ,vol. 6, pp. 3370- 3378 ,(1988) , 10.1096/FASEBJ.6.15.1464371
Reiner Gentz, Jian Ni, Patrick J. Dillon, Guo-Liang Yu, Human 4-1BB receptor splicing variant ,(1997)